Healthcare & Life Science M&A Activity Plummets 1H’22
What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% in Q2 2022, which was in […]
What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% in Q2 2022, which was in […]
Illumina’s attempt to prevent the European Commission from carrying out an antitrust review of its $8 billion takeover last year of cancer diagnosis firm Grail […]
What You Should Know: – Pleno, a multi-omics startup, is emerging out of stealth with a $15M Pre-Series A financing and Greg Lucier as Chairman […]
DNA sequencing power house Illumina sued liquid biopsy company Guardant Health, whose founders used to work for Illumina, claiming the two stole information from Illumina […]
Gene sequencing specialist Illumina has started rolling out a new test that looks for a battery of tumour-associated genes from a single tissue sample, and […]
What You Should Know: – Syapse, a real-world evidence company that informs cancer care, announced a partnership with Illumina aimed at assessing the real-world uptake […]
Genetic tests are becoming available for a wider range of applications. During a CB Insights panel discussion, Phil Febbo of Illumina and Alicia Zhou of […]
A blood test called Galleri that could detect dozens of different forms of cancer before symptoms appear will start trials by the NHS in England […]
In closing its Grail acquisition before U.S. and European regulators sign off, Illumina is taking a chance the deal will pass regulatory muster. It’s a […]
The Federal Trade Commission and the European Union are reviewing the soundness of this acquisition. But if Illumina acquires Grail, the company that it spawned […]
The Federal Trade Commission is opposing Illumina’s proposed $7.1 billion Grail acquisition, arguing that it will reduce competition for multi-cancer early detection tests. Illumina disagrees […]
Read about news from healthcare startups Carrum Health, Turing, and new companies in the Illumina Accelerator program.
What You Should Know: – Illumina and Sequoia Capital will collaborate to build an ecosystem for life science startup companies advancing breakthrough applications in genomics. […]
This year J.P. Morgan 39th Annual Healthcare Conference was conducted virtually and we witnessed multiple announcements from numerous Biopharma companies An analysis of events and […]
The two companies are working together to detect instances of the more contagious B.1.1.7 variant in the U.S. After Colorado identified the first case in […]
Shots: Microsoft enters collaboration with Illumina, Twist, and Western Digital to establish a roadmap for the industry towards the wider use of DNA data storage. […]
Following years of research and investment, liquid biopsies are steadily accumulating FDA approvals. The tests are being used in molecular profiling of solid tumors and […]
Copyright © 2024 | WordPress Theme by MH Themes